缺血性心肌病的阻塞:许多面孔
Muhannad Abbasi1, Kevin C Ong2, D Brian Newman1
1Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
概括
增高性心肌病 (HCM) 涉及心脏肌肉变厚,往往导致外流阻塞. 心声图,特别是多普勒图,是诊断,管理和监测这种遗传性疾病的关键.
科学领域:
- 心脏病学 心脏病学
- 遗传性心血管疾病 遗传性心血管疾病
背景情况:
- 增高性心肌病 (HCM) 是最常见的遗传性心肌病.
- 它的特征是左心室缩不由其他条件引起.
- 增强的actin-myosin相互作用导致心肌过度收缩和潜在的左心室外流通道阻塞.
研究的目的:
- 探索心声回声学在评估HCM中的作用.
- 强调多普勒评估用于识别和监测左心室外流通道阻塞.
- 通过非侵入性血液动力学评估指导治疗决策.
主要方法:
- 使用跨胸腔心声扫描进行查,诊断和风险分层.
- 采用多普勒回声心脏学来评估动态阻塞.
- 在血液动力学评估中采用挑性的动作.
- 审查与解剖学异常相关的心声回声学发现.
主要成果:
- 左心室外流管阻塞发生在75%的HCM患者中,影响预后和症状.
- 心声图提供了至关重要的非侵入性血液动力学评估.
- 多普勒评估对于监测对医疗和干预疗法的反应至关重要.
结论:
- 声心图在HCM的综合管理中是不可或缺的.
- 对阻塞的多普勒评估对于指导治疗策略至关重要.
- 识别阻塞性HCM表型可以为治疗选择提供信息,包括医疗和隔膜缩小疗法.
关键词:
在多普勒测试中,多普勒心声回声扫描 (Echocardiography) 是一种心声回声扫描.过度缩性心肌病变性是一种心脏病变.左心室外流通道阻塞 阻塞左心室外流通道进行肌肉切除术 (myectomy).更多相关视频
相关概念视频
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
Heart Failure Drugs: β-Blockers
338
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
338
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K


